loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 21839 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Ipsen

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MECASERMIN RECOMBINANT (1)

    filter

    01 IPSEN INC (1)

    filter

    01 INJECTABLE;SUBCUTANEOUS (1)

    filter

    01 40MG/4ML (10MG/ML) (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag France
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Mecasermin Recombinant

      PDF Supplier PDF
      URL Supplier Web Content
      INJECTABLE;SUBCUTANEOU...
      40MG/4ML (10MG/ML)
      INCRELEX
      USA
      21839
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 21839

      Looking for CTD TGA MCC DOSSIER APPLICATION 21839 1

      19

      Ipsen, based in France, is a pharmaceutical company.

      One of their notable products is MECASERMIN RECOMBINANT, with a corresponding application number 21839 and regulatory information .

      proudly manufactured in the

      Ipsen's INCRELEX INJECTABLE;SUBCUTANEOUS, medication with 40MG/4ML (10MG/ML) of MECASERMIN RECOMBINANT.

      Post Enquiry
      POST ENQUIRY